Of interest in 2010: the Anthos 2010 microplate reader

Published: 10-Mar-2010
Manufacturing Analysis

Order before 30 June for free software upgrade

When running routine microplate absorbance assays a robust, easy to use microplate reader is needed. The Biochrom Anthos 2010 Microplate Reader is simply designed to meet researchers needs for a quality instrument at a moderate price.

Four filters are supplied as standard that cover the wavelengths for most common absorbance assays with a colorimetric endpoint, e.g. ELISA, BCA, Bradford and Lowry assays, and additional filters are available.

A choice of software packages enables the user to connect to a PC and run both endpoint and kinetic assays with ease. Results can be printed directly or exported to a spreadsheet for further analysis.

Order the Biochrom Anthos 2010 instrument before the end of June 2010 and the user will receive a free software upgrade to program the plate layout with blanks, standards and controls. This permits the user to perform qualitative analysis on the results or quantify unknown samples using a standard curve eliminating outliers.

The Biochrom Anthos range of high performance microplate instrumentation is manufactured by Biochrom and available worldwide.

For complete specifications on the Biochrom Anthos microplate readers as well as the complete Biochrom product line go to www.Biochrom.co.uk
See more

You may also like

Manufacturing

New generation of microplate readers

Read more
Biochrom has a new generation of microplate readers, tailored to meet the needs of modern labs

Trending Articles

  1. Adragos Pharma acquires Sanofi's Maisons-Alfort sterile fill-finish facility to strengthen European injectables network Global CDMO Adragos Pharma has completed the acquisition of one of Europe's largest sterile injectables manufacturing sites from Sanofi in Maisons-Alfort, France, adding high-volume pre-filled syringe capabilities to its existing fill-finish operations in Switzerland and Livron
  2. Swiss Rockets collaborates with Lonza to advance Torqur’s oncology drug candidate bimiralisib into late-stage clinical development Lonza to provide cGMP manufacturing and technical support to advance bimiralisib into late-stage clinical development
  3. Marchesini Group at Interpack 2026 Sustainability, primary packaging, aseptic production, robotics and digital innovation at the heart of this edition
  4. L.B. Bohle hosts successful continuous manufacturing workshop in Brazil Focus on continuous wet granulation and drying for research, development and small-scale production
  5. Symbiosis completes full ICH climatic zone coverage with new stability chamber addition Sterile injectable CDMO Symbiosis Pharmaceutical Services has installed a 30°C stability chamber at its Stirling facility, completing its coverage of all four ICH-defined climatic zones and strengthening its commercial drug product supply capabilities for global markets

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

You may also like

Manufacturing

New generation of microplate readers

Biochrom has a new generation of microplate readers, tailored to meet the needs of modern labs
Manufacturing

Pharmaceutical labelling in focus at Interpack 2026

Well prepared for new requirements. The upcoming reform of EU pharmaceutical legislation is expected to bring stricter requirements for traceability and labelling. The new 152E HC wrap-around labelling machine, developed specifically for contract packers, covers a wide product range with minimal change parts. Also on display: specialised labelling machines for automated product handling of small batches and high-speed labelling applications.
Manufacturing

Virica Biotech and FUJIFILM Biosciences collaborate to boost AAV vector yields in HEK293 manufacturing system

Virica Biotech has announced a collaboration with FUJIFILM Biosciences to co-develop an off-the-shelf enhancer-media solution combining Virica's VSE technology with FUJIFILM's BalanCD HEK293 system, targeting improved AAV productivity and process robustness for gene therapy manufacturers
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Accelerating the development of bispecific antibodies

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains how the use of comprehensive tailored approaches can enhance bispecific antibody productivity, stability and quality while accelerating their delivery to market
Analysis

Conjugation chemistry key to unlocking next-generation oligonucleotide therapies, says Bachem

As demand for oligonucleotide therapeutics accelerates, Bachem's Director of Oligonucleotide Production explains how conjugation chemistry is helping CDMOs overcome delivery challenges
Manufacturing

UK pharmaceutical manufacturers struggling to meet F-Gas compliance amid ageing cooling infrastructure

A new Aggreko report reveals that nearly all UK pharmaceutical manufacturers are facing barriers to upgrading cooling systems ahead of the accelerating F-Gas phase-down timeline
Manufacturing

Labtex - Fresh thinking and innovative solutions

Labtex states: "We are proud to provide unique solutions for laboratories and pilot plants across the UK"
Subscribe now